Healthcare / Medical Care FacilitiesBSE
$15.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-19.8M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
27/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$91M
P/E
107.1x
↑EV/EBITDA
16.1x
↑ROE
0.9%
↑Gross Margin
54.0%
↑Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2026 · 4 años de histórico normalizado
Revenue CAGR
+15.3%
FCF CAGR
—
FCF margin
-33.0%
FCF / Net income
-22.79x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $59.9M · net income $868000.0 · FCF $-19.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $59.9M | $59.9M | $31.8M | $26.1M | $18.2M | $33.9M |
| Net Income | $868000.00 | $868000.00 | $5.4M | $7.0M | $1.4M | $4.6M |
| EBITDA | $5.5M | $5.5M | $8.7M | $10.3M | $8.4M | $10.3M |
| EPS | — | — | 0.98 | 1.15 | 0.23 | 0.76 |
| Gross Margin | 54.0% | 54.0% | 54.4% | 59.7% | 54.0% | 48.2% |
| Operating Margin | 3.5% | 3.5% | 21.9% | 36.5% | 19.7% | 27.8% |
| Net Margin | 1.4% | 1.4% | 16.9% | 26.8% | 7.6% | 13.5% |
| Balance Sheet | ||||||
| Debt/Equity | — | — | 0.11 | — | 2.74 | 1.13 |
| Current Ratio | 3.09 | 3.09 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $-19.8M | $-19.8M | $-10.2M | $-47.0M | $-28.3M | $-17.6M |
| Returns | ||||||
| ROE | 0.9% | 0.9% | 5.7% | 12.8% | 6.4% | 20.4% |
| Valuation | ||||||
| P/E | 107.14 | 107.14 | 19.64 | — | — | — |
| EV/EBITDA | 16.05 | 16.05 | 13.03 | — | — | — |
| P/B | 0.96 | 0.96 | 1.12 | — | — | — |
| Growth & Yield | ||||||
| Revenue Growth | 88.5% | 88.5% | 22.0% | 43.5% | — | — |
| EPS Growth | — | — | -14.7% | 403.7% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.